Indicated for: HIV-1 infection
Substance: nelfinavir (antiretroviral)
ATC: J05AE04 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Nelfinavir is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, preventing viral replication.
The medication is taken orally, as directed by a doctor, usually two or three times daily with food. It is important for patients to follow the treatment regimen to prevent the development of viral resistance.
Patients should be aware of potential side effects, such as diarrhea, nausea, or abdominal pain. It is important to inform the doctor of any unusual symptoms.
Common side effects include diarrhea, nausea, and abdominal pain. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.